Literature DB >> 30596185

Taqman Assay for Genotyping CKD-Associated APOL1 SNP rs60910145: A Cautionary Note.

Victor A David1, Elizabeth A Binns-Roemer2, Cheryl A Winkler2.   

Abstract

Entities:  

Year:  2018        PMID: 30596185      PMCID: PMC6308993          DOI: 10.1016/j.ekir.2018.09.018

Source DB:  PubMed          Journal:  Kidney Int Rep        ISSN: 2468-0249


× No keyword cloud information.
To the Editor: There are 2 APOL1 variant haplotypes, G1 and G2, that predispose individuals of African descent to a diverse spectrum of chronic kidney disease in the homozygous (G1/G1 or G2/G2) or compound heterozygous state (G1/G2).1, 2 The G1 haplotype (approximately 23% of African Americans) carries 2 nonsynonymous variants: rs73885319 (p.S342G) and rs60910145 (p.I384M). Genotyping rs73885319 is generally sufficient, as the 2 single-nucleotide polymorphisms (SNPs) are in near-absolute linkage disequilibrium; however, researchers often genotype both G1 variants for quality control purposes and to distinguish between 2 G1 sub-haplotypes: G1GM (has both S242G and I384M amino acid substitutions) and the rare G1G+ (only the S242G substitution). The G2 haplotype harbors a 6–base pair in-frame deletion (rs71785313, also known as rs143830837, approximate 13% frequency in African Americans). We use custom Taqman assays for these SNPs: rs73885319 (Assay ID-AH20SD1), rs60910145 (Assay ID-AHWR1JA), and RS71785313 (Assay ID-AH1RT7T). Many laboratories type the APOL1 SNPs using Taqman assays that are available from ThermoFisher Scientific (Waltham, MA) as predesigned assays. The ThermoFisher Web site notes that one of the polymerase chain reaction primers for rs60910145 (Assay ID-C__89555688_10) spans the 6–base pair deletion of the G2 SNP. We found that the presence of the 6–base pair deletion results in a failure of amplification of the rs60910145 allele on the G2 haplotype. Thus, the G2/G2 haplotype will fail to amplify for rs60910145, and G1GM/G2 individuals will fail to amplify the rs60910145 allele on the G2 haplotype and be scored as homozygous for the variant nucleotide instead of heterozygous (Table 1). Although the G2 SNP is absent or rare in Asian and white individuals, and thus will not affect RS60910145 typing in those populations, most investigators are typing RS60910145 in populations of African descent in which G2 is much more common. We have typed a set of 1110 African American samples with the 2 different versions of the rs60910145 assay, as well as rs73885319 and rs143830837, and confirmed this result (7.3% of the rs60910145 genotypes obtained with the predesigned assay failed or gave the incorrect genotype). Specifically, with the predesigned assay, 1.4% of the samples tested had a G2/G2 genotype, so the RS60910145 amplification failed, and 5.9% of the samples had the G1GM,G2 genotype, and they were incorrectly typed as G instead of GT at RS60910145. When the incorrect RS60910145 result for the G1GM,G2 genotype samples is combined with results from the rs73885319 and rs71785313 SNP assays, it will result in an inferred haplotype never actually observed on African chromosomes. (Table 2)
Table 1

Taqman SNP typing with the predesigned rs60910145 (C__89555688_10) assay results in errors in some individuals with the G2 allele: haplotypea

RS73885319 (p.S242G)RS60910145 (p.I384M)RS71785313 (p.N388_Y389del)Amplification of RS60910145 with predesigned primer
Haplotype
G0ATIYes
G1GMGGIYes
G1G+GTIYes
G2ATDNo

Derived allele in bold.

Table 2

Taqman SNP typing with the predesigned rs60910145 (C__89555688_10) assay results in errors in some individuals with the G2 allele: genotypes observed in a survey population of 1110 African American samples

Genotypers60910145 assay
Frequency observed, %
Custom assayPredesigned assay
G0,G0TT47.5
G0,G1GMGTGT25.7
G0,G1G+TT0.3
G1GM,G1GMGG4.1
G1GM,G1G+GTGT0.5
G0,G2TT14.5
G1GM,G2GTGa5.9
G2,G2TNo amplification1.4

When combined with results from the rs73885319 and rs71785313 SNP assays, will result in an inferred haplotype not observed on African chromosomes.

Taqman SNP typing with the predesigned rs60910145 (C__89555688_10) assay results in errors in some individuals with the G2 allele: haplotypea Derived allele in bold. Taqman SNP typing with the predesigned rs60910145 (C__89555688_10) assay results in errors in some individuals with the G2 allele: genotypes observed in a survey population of 1110 African American samples When combined with results from the rs73885319 and rs71785313 SNP assays, will result in an inferred haplotype not observed on African chromosomes. It is important to avoid the rs71785313 deletion while designing genotyping probes or primers for the APOL1 region. ThermoFisher has been made aware of this problem and plans to replace the commercial assay for rs60910145 with the custom-designed assay (Assay ID-AHWR1JA). Investigators who have used the ThermoFisher predesigned assay are cautioned that rs60910145 results using the predesigned ThermoFisher assay are not reliable. It is difficult to ascertain from the literature which Taqman assay investigators use, because they do not typically report the part number for the RS60910145 assay. Although the custom-designed assay for rs60910145 is not listed on the ThermoFisher Web site, it can be purchased by specifying RS60910145 Assay ID-AHWR1JA.
  5 in total

1.  Alpha Globin Gene Copy Number Is Associated with Prevalent Chronic Kidney Disease and Incident End-Stage Kidney Disease among Black Americans.

Authors:  A Parker Ruhl; Neal Jeffries; Yu Yang; Rakhi P Naik; Amit Patki; Lydia H Pecker; Bryan T Mott; Neil A Zakai; Cheryl A Winkler; Jeffrey B Kopp; Leslie A Lange; Marguerite R Irvin; Orlando M Gutierrez; Mary Cushman; Hans C Ackerman
Journal:  J Am Soc Nephrol       Date:  2021-10-27       Impact factor: 10.121

2.  APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population.

Authors:  Anne Cornelissen; Daniela T Fuller; Raquel Fernandez; Xiaoqing Zhao; Robert Kutys; Elizabeth Binns-Roemer; Marco Delsante; Atsushi Sakamoto; Ka Hyun Paek; Yu Sato; Rika Kawakami; Masayuki Mori; Kenji Kawai; Teruhiko Yoshida; Khun Zaw Latt; Clint L Miller; Paul S de Vries; Frank D Kolodgie; Renu Virmani; Myung Kyun Shin; Maarten Hoek; Jurgen Heymann; Jeffrey B Kopp; Avi Z Rosenberg; Harry R Davis; Liang Guo; Aloke V Finn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-05-27       Impact factor: 10.514

3.  Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria.

Authors:  Usman J Wudil; Muktar H Aliyu; Heather L Prigmore; Donna J Ingles; Aima A Ahonkhai; Baba M Musa; Hamza Muhammad; Mahmoud U Sani; Aisha M Nalado; Aliyu Abdu; Kabiru Abdussalam; Bryan E Shepherd; Faisal S Dankishiya; Anna M Burgner; T Alp Ikizler; Christina M Wyatt; Jeffrey B Kopp; Paul L Kimmel; Cheryl A Winkler; C William Wester
Journal:  Kidney Int       Date:  2021-04-24       Impact factor: 18.998

4.  Joint Associations of Maternal-Fetal APOL1 Genotypes and Maternal Country of Origin With Preeclampsia Risk.

Authors:  Xiumei Hong; Avi Z Rosenberg; Boyang Zhang; Elizabeth Binns-Roemer; Victor David; Yiming Lv; Rebecca C Hjorten; Kimberly J Reidy; Teresa K Chen; Guoying Wang; Yuelong Ji; Claire L Simpson; Robert L Davis; Jeffrey B Kopp; Xiaobin Wang; Cheryl A Winkler
Journal:  Am J Kidney Dis       Date:  2020-12-22       Impact factor: 11.072

5.  Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV.

Authors:  Rachel K Y Hung; Elizabeth Binns-Roemer; John W Booth; Rachel Hilton; Mark Harber; Beatriz Santana-Suarez; Lucy Campbell; Julie Fox; Andrew Ustianowski; Catherine Cosgrove; James E Burns; Amanda Clarke; David A Price; David Chadwick; Denis Onyango; Lisa Hamzah; Kate Bramham; Caroline A Sabin; Cheryl A Winkler; Frank A Post
Journal:  Kidney Int Rep       Date:  2022-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.